China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition

AI Briefing

• – China approves Pfizer's GLP-1 drug for weight management
• – Escalating market competition with Novo, Lilly and others
• – Generic versions of ecnoglutide expected to emerge soon